Content

Welcome to the CJU website » LOG IN

Details

Measuring the minimum clinically important difference in BPH outcome measures
Assistant Professor, University of Ottawa, Ottawa General Hospital, Ottawa, Onta
Jun 1997 (Vol. 4, Issue 2, Pages( 377 - 380)

    Abstract

    Text-Size + 

  • PURPOSE: To determine the minimum clinically important difference with respect to the different outcome measures used in benign prostatic hyperplasia (BPH) research. MATERIALS AND METHODS: Forty-two patients diagnosed with symptomatic BPH were prospectively recruited from community urology clinics. Patients were asked at follow-up visits to rate their improvement using a self-administrated questionnaire. The improvement score was then compared to the changes from baseline in each of the outcome measures. RESULTS: Maximum and mean flow-rates did not correlate significantly with the patient's improvement measure. The Boyarsky score correlated best with the patient's grading of overall improvement (R=.507, p<.001). The mean change in Boyarsky symptom score for patients with a small improvement was 3.23 (sd=3.52).

Current Issue

Apr 2017, Vol.24 No.2
canadian journal of urology mobile

canadian journal of urology